Literature DB >> 19221853

Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies.

N C Voermans1, C G Bonnemann, B C J Hamel, H Jungbluth, B G van Engelen.   

Abstract

Congenital and adult-onset inherited myopathies represent a wide spectrum of syndromes. Classification is based upon clinical features and biochemical and genetic defects. Joint hypermobility is one of the distinctive clinical features that has often been underrecognized so far. We therefore present an overview of myopathies associated with joint hypermobility: Ullrich congenital muscular dystrophy, Bethlem myopathy, congenital muscular dystrophy with joint hyperlaxity, multi-minicore disease, central core disease, and limb girdle muscular dystrophy 2E with joint hyperlaxity and contractures. We shortly discuss a second group of disorders characterised by both muscular features and joint hypermobility: the inherited disorders of connective tissue Ehlers-Danlos syndrome and Marfan syndrome. Furthermore, we will briefly discuss the extent and pattern of joint hypermobility in these myopathies and connective tissue disorders and propose two grading scales commonly used to score the severity of joint hypermobility. We will conclude focusing on the various molecules involved in these disorders and on their role and interactions in muscle and tendon, with a view to further elucidate the pathophysiology of combined hypermobility and myopathy. Hopefully, this review will contribute to enhanced recognition of joint hypermobility and thus be of aid in differential diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19221853     DOI: 10.1007/s00415-009-0105-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  65 in total

1.  Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.

Authors:  Yaqun Zou; Rui-Zhu Zhang; Patrizia Sabatelli; Mon-Li Chu; Carsten G Bönnemann
Journal:  J Neuropathol Exp Neurol       Date:  2008-02       Impact factor: 3.685

2.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

Review 3.  Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.

Authors:  H N Yeowell; L C Walker
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

4.  Muscle strength and body composition in adult women with Marfan syndrome.

Authors:  G Percheron; G Fayet; T Ningler; J-M Le Parc; S Denot-Ledunois; M Leroy; B Raffestin; G Jondeau
Journal:  Rheumatology (Oxford)       Date:  2007-02-28       Impact factor: 7.580

5.  A mutation in the human ryanodine receptor gene associated with central core disease.

Authors:  Y Zhang; H S Chen; V K Khanna; S De Leon; M S Phillips; K Schappert; B A Britt; A K Browell; D H MacLennan
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

6.  Neurologic manifestations of Ehlers-Danlos syndrome.

Authors:  M E Pretorius; I J Butler
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

7.  Orthopaedic aspects of central core disease.

Authors:  J G Gamble; L A Rinsky; J H Lee
Journal:  J Bone Joint Surg Am       Date:  1988-08       Impact factor: 5.284

8.  Ageing in Marfan syndrome.

Authors:  A Hasan; J Poloniecki; A Child
Journal:  Int J Clin Pract       Date:  2007-08       Impact factor: 2.503

9.  Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.

Authors:  H Zhang; W Hu; F Ramirez
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

Review 10.  Central core disease.

Authors:  Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2007-05-15       Impact factor: 4.123

View more
  13 in total

1.  Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation.

Authors:  N C Voermans; M Kempers; M Lammens; N van Alfen; M C Janssen; C Bönnemann; B G van Engelen; B C Hamel
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

Review 2.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

3.  Anesthetic Management of a Patient With Ehlers-Danlos Syndrome.

Authors:  Naohiro Ohshita; Masahiko Kanazumi; Kaname Tsuji; Hiroaki Yoshida; Shosuke Morita; Yoshihiro Momota; Yasuo M Tsutsumi
Journal:  Anesth Prog       Date:  2016

Review 4.  The collagen VI-related myopathies: muscle meets its matrix.

Authors:  Carsten G Bönnemann
Journal:  Nat Rev Neurol       Date:  2011-06-21       Impact factor: 42.937

5.  Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells.

Authors:  Dianne Little; Farshid Guilak; David S Ruch
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

Review 6.  Movement Disorders and Musculoskeletal System: A Reciprocal Relationship.

Authors:  Sanjay Pandey; Anjali Chouksey; Yuvadee Pitakpatapee; Prachaya Srivanitchapoom
Journal:  Mov Disord Clin Pract       Date:  2021-12-16

7.  Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

Authors:  Emre Erbabacan; Güniz M Köksal; Tuğçe Barça Şeker; Birsel Ekici; Rahsan Özcan; Fatiş Altindaş
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

8.  Approach to the diagnosis of congenital myopathies.

Authors:  Kathryn N North; Ching H Wang; Nigel Clarke; Heinz Jungbluth; Mariz Vainzof; James J Dowling; Kimberly Amburgey; Susana Quijano-Roy; Alan H Beggs; Caroline Sewry; Nigel G Laing; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2013-11-18       Impact factor: 4.296

Review 9.  Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

Authors:  Marco Castori; Nicol C Voermans
Journal:  Iran J Neurol       Date:  2014-10-06

10.  Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations.

Authors:  Marco Castori
Journal:  ISRN Dermatol       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.